参考文献/References:
[1] ZHAO Yanlin, XU Shaofa, WANG Lixia, et al.National survey of drug-resistant tuberculosis inChina[J]. The New England Journal of Medicine, 2012,366(23): 2161-2170.
[2] ALBERT H, BWANGA F, MUKKADA S, et al.Rapid screening of MDR-TB using molecular LineProbe Assay is feasible in Uganda[J]. BMC infectiousdiseases, 2010, 10(1):41.
[3] World Health Organization. Molecular line probe assaysfor rapid screening of patients at risk of multidrugresistanttuberculosis (MDR-TB): policy statement[EB].Geneva: World Health Organization, 2008.http://www.who.int/tb/features_archive/policy_statement.pdf.
[4] 许蕴怡，蔡杏珊，刘燕文，等．PCR 线性杂交酶显色法与BD960 液体法在耐多药结核杆菌药敏结果的对比分析[J]．现代医院，2016，16（4）：529-531.XU Yunyi, CAI Xingshan, LIU Yanwen, et al.The results of multidrug-resistant Mycobacteriumtuberculosis drug susceptibility between linear hybridenzyme coloration method and BD960 susceptibilitymethed[J]．Modern Hospital, 2016, 16(4):529-531.
[5] 崔俊伟，蔡瑞艳，王永亮．分子线性探针杂交法在结核分枝杆菌耐药性快速检测中的应用价值[J]. 新乡医学院学报,2017,34(10):920-923.CUI Junwei, CAI Ruiyan,WANG Yongliang.Application value of molecular linear probehybridization in rapid detection of drug resistance ofMycobacterium tuberculosis[J].Journal of XinxiangMedical University. 2017,34(10):920-923.
[6] 刘元, 周俊, 崔晓利, 等.GeneXpert MTB/RIF 检测结核分枝杆菌对利福平耐药假阳性与标本低水平荷菌量的关系[J]. 中国防痨杂志, 2019, 41(2):176-180.LIU Yuan, ZHOU Jun, CUI Xiaoli ,et al. Therelationship between false-positive rifampicin resistantresults of GeneXpert MTB/RIF and very low bacterialload in the clinical samples[J]. Chinese Journal ofAntituberculosis. 2019,41(2):176-180.
[7] KUMARI R, TRIPATHI R, PANDEY A P, et al. Rapidscreening of MDR-TB in cases of extra pulmonarytuberculosis using Geno type MTBDRplus[J]. PLoSOne, 2016, 11(7): e0159651.
[8] GHANEKAR C, PATEL D, ABHYANKAR M, etal. Role of line probe assay in detection of extrapulmonarytuberculosis: Experience from a tertiary carehospital in western Maharashtra[J]. The Indian Journalof Tuberculosis, 2019, 66(3): 325-330.
[9] 李仁忠，王黎霞．实验室新技术用于耐药结核病诊断流程的建议[J]．中华结核和呼吸杂志，2016，39(7)：568-569．LI Renzhong, WANG Lixia. Suggestion of newlaboratory technology for drug resistant tuberculosisdiagnosis process[J]．Chinese Journal of Tuberculosisand Respiratory Diseases,2016,39(7):568-569.
[10] SOARES V M, ALMEIDA I N D, VATER M C, et al.Genotype?MTBDRplus and xpert?MTB/RIF in thediagnosis of tuberculosis and resistant tuberculosis:costanalysis in a tertiary referral hospital[J].Revista daSociedade Brasileira de Medicina Tropical, 2020,53(34): e20190175.
[11] 张培莉，刘义庆，邵婧，等. 结核感染T 淋巴细胞IFN-r 释放实验临床检测分析[J]. 现代检验医学杂志,2017,32(1):22-25,29.ZHANG Peili, LIU Yiqing,SHAO Jing,et al. Interferongamma release assays from T lymphocytes in patientswith tuberculosis infection[J]. Journal of ModernLaboratory Medicine,2017,32(1) : 22,25,29.
[12] L? Chunfang, WU Jianhong, PIERRE-AUDIGIER C,et al. Combination of xpert MTB/RIF and MTBDRplusfor diagnosing tuberculosis in a Chinese district[J].Medical Science Monitor ,2020.26:e923508
[13] 廖东宁，熊志刚，刘庆华．口服氨溴索提高肺结核痰涂片阳性检出率的应用观察[J]. 现代检验医学杂志,2017,32(4):145-147.LIAO Dongning，XIONG Zhigang，LIU Qinghua.Observation and application of oral ambroxol inimproving positive rate of tuberculosis laboratory testby sputum smear[J]．Journal of Modern LaboratoryMedicine,2017,32(4) : 145-147.
相似文献/References:
[1]杨 健,王西娣,陈美玲,等.2013～2015年陕西地区结核分枝杆菌对利福平耐药性及rpoB基因突变的相关研究[J].现代检验医学杂志,2016,31(02):53.[doi:10.3969/j.issn.1671-7414.2016.02.016]
YANG Jian,WANG Xi-di,CHEN Mei-ling,et al.Related Research on Resistance of Mycobacterium Tuberculosis
to Rifampin and rpoB Gene Mutations in Shaanxi from 2013 to 2015[J].Journal of Modern Laboratory Medicine,2016,31(04):53.[doi:10.3969/j.issn.1671-7414.2016.02.016]
[2]张 洁,齐红伟,丁北川,等.结核分枝杆菌临床分离株对吡嗪酰胺的药物敏感性分析[J].现代检验医学杂志,2017,32(03):49.[doi:10.3969/j.issn.1671-7414.2017.03.013]
ZHANG Jie,QI Hong-wei,DING Bei-chuan,et al.Analysis on Pyrazinamide Drug Susceptibility of
Mycobacterium Tuberculosis Clinical Strains[J].Journal of Modern Laboratory Medicine,2017,32(04):49.[doi:10.3969/j.issn.1671-7414.2017.03.013]
[3]吴晓康,周维肖,冯 楠,等.影响TB-IGRA检测结果的因素分析及应对措施[J].现代检验医学杂志,2018,33(04):154.[doi:10.3969/j.issn.1671-7414.2018.04.043]
WU Xiao-kang,ZHOU Wei-xiao,FENG Nan,et al.Analysis of Factors Influencing TB-IGRA
Detection Results and Solutions[J].Journal of Modern Laboratory Medicine,2018,33(04):154.[doi:10.3969/j.issn.1671-7414.2018.04.043]
[4]谭玉华,朱应竹,江 燚,等.时间分辨免疫荧光法检测结核感染T细胞释放γ-干扰素的方法建立及初步临床应用[J].现代检验医学杂志,2018,33(06):21.[doi:10.3969/j.issn.1671-7414.2018.06.006]
TAN Yu-hua,ZHU Ying-zhu,JIANG Yi,et al.Establishment and Preliminary Clinical Application of Interferon Gamma Release Assays for T Cells Infected With Mycobacterium Tuberculosis Based on Time-Resolved Fluoroimmunoassay[J].Journal of Modern Laboratory Medicine,2018,33(04):21.[doi:10.3969/j.issn.1671-7414.2018.06.006]
[5]田斌,文岚,刘燕萍,等.QFT-GIT对儿童肺结核临床诊断价值的meta分析[J].现代检验医学杂志,2019,34(01):89.[doi:10.3969/j.issn.1671-7414.2019.01.023]
TIAN Bin,WEN Lan,LIU Yan-ping,et al.Clinical Usefulness of QuantiFERON-TB Gold In-Tube(QFT-GIT) Te
st
for Tuberculosis Diagnosis in Children：A Systematic Review[J].Journal of Modern Laboratory Medicine,2019,34(04):89.[doi:10.3969/j.issn.1671-7414.2019.01.023]
[6]丁 磊,徐俊驰,邱文娜,等.结核分枝杆菌耐药机制和治疗的最新研究进展[J].现代检验医学杂志,2021,36(02):1.[doi:doi:10.3969/j.issn.1671-7414.2021.02.001]
DING Lei,XU Jun-chi,QIU Wen-na,et al.Latest Research Progress on the Drug Resistance Mechanism and Treatment of Mycobacterium Tuberculosis[J].Journal of Modern Laboratory Medicine,2021,36(04):1.[doi:doi:10.3969/j.issn.1671-7414.2021.02.001]